BCDA
Price
$0.38
Change
-$0.00 (-0.00%)
Updated
May 3, 6:59 PM EST
4 days until earnings call
STOK
Price
$12.02
Change
+$0.33 (+2.82%)
Updated
May 3, 6:59 PM EST
3 days until earnings call
Ad is loading...

Compare trend and price BCDA vs STOK

Header iconBCDA vs STOK Comparison
Open Charts BCDA vs STOKBanner chart's image
BioCardia
Price$0.38
Change-$0.00 (-0.00%)
Volume$32.47K
CapitalizationN/A
Stoke Therapeutics
Price$12.02
Change+$0.33 (+2.82%)
Volume$307.92K
CapitalizationN/A
View a ticker or compare two or three
BCDA vs STOK Comparison Chart

Loading...

BCDADaily Signal changed days agoGain/Loss if shorted
 
Show more...
STOKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BCDA vs. STOK commentary
May 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCDA is a Hold and STOK is a Hold.

COMPARISON
Comparison
May 05, 2024
Stock price -- (BCDA: $0.38 vs. STOK: $12.02)
Brand notoriety: BCDA and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCDA: 20% vs. STOK: 33%
Market capitalization -- BCDA: $10.21M vs. STOK: $626.45M
BCDA [@Biotechnology] is valued at $10.21M. STOK’s [@Biotechnology] market capitalization is $626.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $559.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCDA’s FA Score shows that 0 FA rating(s) are green whileSTOK’s FA Score has 0 green FA rating(s).

  • BCDA’s FA Score: 0 green, 5 red.
  • STOK’s FA Score: 0 green, 5 red.
According to our system of comparison, STOK is a better buy in the long-term than BCDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCDA’s TA Score shows that 4 TA indicator(s) are bullish while STOK’s TA Score has 5 bullish TA indicator(s).

  • BCDA’s TA Score: 4 bullish, 3 bearish.
  • STOK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both BCDA and STOK are a good buy in the short-term.

Price Growth

BCDA (@Biotechnology) experienced а +0.88% price change this week, while STOK (@Biotechnology) price change was -3.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was -3.94%, and the average quarterly price growth was +1240.85%.

Reported Earning Dates

BCDA is expected to report earnings on Aug 07, 2024.

STOK is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCDA with price predictions.
OPEN
A.I.dvisor published
a Summary for STOK with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
STOK($626M) has a higher market cap than BCDA($10.2M). STOK YTD gains are higher at: 128.517 vs. BCDA (-42.803).
BCDASTOKBCDA / STOK
Capitalization10.2M626M2%
EBITDAN/AN/A-
Gain YTD-42.803128.517-33%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
BCDA: Fundamental Ratings
BCDA
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
2

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCDASTOK
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 4 days ago
78%
View a ticker or compare two or three
Ad is loading...
BCDADaily Signal changed days agoGain/Loss if shorted
 
Show more...
STOKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPTN1.010.13
+15.09%
OptiNose
SWKS92.512.79
+3.11%
Skyworks Solutions
MTTR4.540.03
+0.67%
Matterport
ACAD17.05-0.03
-0.18%
ACADIA Pharmaceuticals
CPOP1.60-0.02
-1.23%
Pop Culture Group Co Ltd

BCDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCDA has been loosely correlated with LABP. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BCDA jumps, then LABP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCDA
1D Price
Change %
BCDA100%
+1.31%
LABP - BCDA
35%
Loosely correlated
-0.07%
LYEL - BCDA
30%
Poorly correlated
-1.67%
MDGL - BCDA
29%
Poorly correlated
+6.38%
INO - BCDA
28%
Poorly correlated
+0.75%
STOK - BCDA
28%
Poorly correlated
+2.82%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with NUVB. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
+2.82%
NUVB - STOK
49%
Loosely correlated
-1.53%
INZY - STOK
45%
Loosely correlated
+1.94%
QTTB - STOK
44%
Loosely correlated
-0.70%
STRO - STOK
43%
Loosely correlated
-2.79%
KOD - STOK
40%
Loosely correlated
+1.89%
More